Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 11Sarcoma 10Gastrointestinal 9Genitourinary 8Gynecologic 7Thoracic 4Endocrine 4Tumor-Agnostic 3Other hematologic neoplasm 3Lymphoid 3Myeloid 2Dermatologic 2CNS 2Plasma cell 1Other solid neoplasm 1NET 1Head & Neck 1Classical hematology 1

Conditions

Neuroendocrine Tumors 2Neoplasms 2Neoplasm Metastasis 1

Interventions

Everolimus 3tislelizumab 1surufatinib 1romidepsin 1regorafenib 1pembrolizumab 1pasireotide 1lutetium Lu 177 dotatate 1folfirinox 1fludarabine phosphate 1epothilone B 1cixutumumab 1Surgical Procedures, Operative 1Sunitinib 1Specimen Handling 1Radiosurgery 1Octreotide 1Magnetic Resonance Spectroscopy 1Liver Transplantation 1Lactones 1LY2584702 1Interleukin-13 1Granulocyte Colony-Stimulating Factor 1Fluorodeoxyglucose F18 1Filgrastim 1Erlotinib Hydrochloride 1Embolization, Therapeutic 1Doxorubicin 1Depsipeptides 1Cytokines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Doxorubicin × NET × Clear all
NCT01678664 2024-09-25

EVACEL

Federation Francophone de Cancerologie Digestive

Phase 2 Completed
74 enrolled 10 charts
EndocrineNET

Neoplasm Metastasis, Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡